🇺🇸 FDA
Patent

US 7854932

Immunogenic compositions comprising progastrin and uses thereof

granted A61KA61K38/2207A61K39/0005

Quick answer

US patent 7854932 (Immunogenic compositions comprising progastrin and uses thereof) held by The Board of Regents of the University of Texas System expires Mon Dec 16 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Dec 21 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 16 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K38/2207, A61K39/0005, A61K39/001102, A61K45/06